Cargando…

Head and neck paragangliomas: clinical and molecular genetic classification

Head and neck paragangliomas are tumors arising from specialized neural crest cells. Prominent locations are the carotid body along with the vagal, jugular, and tympanic glomus. Head and neck paragangliomas are slowly growing tumors, with some carotid body tumors being reported to exist for many yea...

Descripción completa

Detalles Bibliográficos
Autores principales: Offergeld, Christian, Brase, Christoph, Yaremchuk, Svetlana, Mader, Irina, Rischke, Hans Christian, Gläsker, Sven, Schmid, Kurt W, Wiech, Thorsten, Preuss, Simon F, Suárez, Carlos, Kopeć, Tomasz, Patocs, Attila, Wohllk, Nelson, Malekpour, Mahdi, Boedeker, Carsten C, Neumann, Hartmut PH
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3328838/
https://www.ncbi.nlm.nih.gov/pubmed/22584701
http://dx.doi.org/10.6061/clinics/2012(Sup01)05
_version_ 1782229781066022912
author Offergeld, Christian
Brase, Christoph
Yaremchuk, Svetlana
Mader, Irina
Rischke, Hans Christian
Gläsker, Sven
Schmid, Kurt W
Wiech, Thorsten
Preuss, Simon F
Suárez, Carlos
Kopeć, Tomasz
Patocs, Attila
Wohllk, Nelson
Malekpour, Mahdi
Boedeker, Carsten C
Neumann, Hartmut PH
author_facet Offergeld, Christian
Brase, Christoph
Yaremchuk, Svetlana
Mader, Irina
Rischke, Hans Christian
Gläsker, Sven
Schmid, Kurt W
Wiech, Thorsten
Preuss, Simon F
Suárez, Carlos
Kopeć, Tomasz
Patocs, Attila
Wohllk, Nelson
Malekpour, Mahdi
Boedeker, Carsten C
Neumann, Hartmut PH
author_sort Offergeld, Christian
collection PubMed
description Head and neck paragangliomas are tumors arising from specialized neural crest cells. Prominent locations are the carotid body along with the vagal, jugular, and tympanic glomus. Head and neck paragangliomas are slowly growing tumors, with some carotid body tumors being reported to exist for many years as a painless lateral mass on the neck. Symptoms depend on the specific locations. In contrast to paraganglial tumors of the adrenals, abdomen and thorax, head and neck paragangliomas seldom release catecholamines and are hence rarely vasoactive. Petrous bone, jugular, and tympanic head and neck paragangliomas may cause hearing loss. The internationally accepted clinical classifications for carotid body tumors are based on the Shamblin Class I–III stages, which correspond to postoperative permanent side effects. For petrous-bone paragangliomas in the head and neck, the Fisch classification is used. Regarding the molecular genetics, head and neck paragangliomas have been associated with nine susceptibility genes: NF1, RET, VHL, SDHA, SDHB, SDHC, SDHD, SDHAF2 (SDH5), and TMEM127. Hereditary HNPs are mostly caused by mutations of the SDHD gene, but SDHB and SDHC mutations are not uncommon in such patients. Head and neck paragangliomas are rarely associated with mutations of VHL, RET, or NF1. The research on SDHA, SDHAF2 and TMEM127 is ongoing. Multiple head and neck paragangliomas are common in patients with SDHD mutations, while malignant head and neck paraganglioma is mostly seen in patients with SDHB mutations. The treatment of choice is surgical resection. Good postoperative results can be expected in carotid body tumors of Shamblin Class I and II, whereas operations on other carotid body tumors and other head and neck paragangliomas frequently result in deficits of the cranial nerves adjacent to the tumors. Slow growth and the tendency of hereditary head and neck paragangliomas to be multifocal may justify less aggressive treatment strategies.
format Online
Article
Text
id pubmed-3328838
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
record_format MEDLINE/PubMed
spelling pubmed-33288382012-04-19 Head and neck paragangliomas: clinical and molecular genetic classification Offergeld, Christian Brase, Christoph Yaremchuk, Svetlana Mader, Irina Rischke, Hans Christian Gläsker, Sven Schmid, Kurt W Wiech, Thorsten Preuss, Simon F Suárez, Carlos Kopeć, Tomasz Patocs, Attila Wohllk, Nelson Malekpour, Mahdi Boedeker, Carsten C Neumann, Hartmut PH Clinics (Sao Paulo) Review Head and neck paragangliomas are tumors arising from specialized neural crest cells. Prominent locations are the carotid body along with the vagal, jugular, and tympanic glomus. Head and neck paragangliomas are slowly growing tumors, with some carotid body tumors being reported to exist for many years as a painless lateral mass on the neck. Symptoms depend on the specific locations. In contrast to paraganglial tumors of the adrenals, abdomen and thorax, head and neck paragangliomas seldom release catecholamines and are hence rarely vasoactive. Petrous bone, jugular, and tympanic head and neck paragangliomas may cause hearing loss. The internationally accepted clinical classifications for carotid body tumors are based on the Shamblin Class I–III stages, which correspond to postoperative permanent side effects. For petrous-bone paragangliomas in the head and neck, the Fisch classification is used. Regarding the molecular genetics, head and neck paragangliomas have been associated with nine susceptibility genes: NF1, RET, VHL, SDHA, SDHB, SDHC, SDHD, SDHAF2 (SDH5), and TMEM127. Hereditary HNPs are mostly caused by mutations of the SDHD gene, but SDHB and SDHC mutations are not uncommon in such patients. Head and neck paragangliomas are rarely associated with mutations of VHL, RET, or NF1. The research on SDHA, SDHAF2 and TMEM127 is ongoing. Multiple head and neck paragangliomas are common in patients with SDHD mutations, while malignant head and neck paraganglioma is mostly seen in patients with SDHB mutations. The treatment of choice is surgical resection. Good postoperative results can be expected in carotid body tumors of Shamblin Class I and II, whereas operations on other carotid body tumors and other head and neck paragangliomas frequently result in deficits of the cranial nerves adjacent to the tumors. Slow growth and the tendency of hereditary head and neck paragangliomas to be multifocal may justify less aggressive treatment strategies. Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2012-04 /pmc/articles/PMC3328838/ /pubmed/22584701 http://dx.doi.org/10.6061/clinics/2012(Sup01)05 Text en Copyright © 2012 Hospital das Clínicas da FMUSP http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Offergeld, Christian
Brase, Christoph
Yaremchuk, Svetlana
Mader, Irina
Rischke, Hans Christian
Gläsker, Sven
Schmid, Kurt W
Wiech, Thorsten
Preuss, Simon F
Suárez, Carlos
Kopeć, Tomasz
Patocs, Attila
Wohllk, Nelson
Malekpour, Mahdi
Boedeker, Carsten C
Neumann, Hartmut PH
Head and neck paragangliomas: clinical and molecular genetic classification
title Head and neck paragangliomas: clinical and molecular genetic classification
title_full Head and neck paragangliomas: clinical and molecular genetic classification
title_fullStr Head and neck paragangliomas: clinical and molecular genetic classification
title_full_unstemmed Head and neck paragangliomas: clinical and molecular genetic classification
title_short Head and neck paragangliomas: clinical and molecular genetic classification
title_sort head and neck paragangliomas: clinical and molecular genetic classification
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3328838/
https://www.ncbi.nlm.nih.gov/pubmed/22584701
http://dx.doi.org/10.6061/clinics/2012(Sup01)05
work_keys_str_mv AT offergeldchristian headandneckparagangliomasclinicalandmoleculargeneticclassification
AT brasechristoph headandneckparagangliomasclinicalandmoleculargeneticclassification
AT yaremchuksvetlana headandneckparagangliomasclinicalandmoleculargeneticclassification
AT maderirina headandneckparagangliomasclinicalandmoleculargeneticclassification
AT rischkehanschristian headandneckparagangliomasclinicalandmoleculargeneticclassification
AT glaskersven headandneckparagangliomasclinicalandmoleculargeneticclassification
AT schmidkurtw headandneckparagangliomasclinicalandmoleculargeneticclassification
AT wiechthorsten headandneckparagangliomasclinicalandmoleculargeneticclassification
AT preusssimonf headandneckparagangliomasclinicalandmoleculargeneticclassification
AT suarezcarlos headandneckparagangliomasclinicalandmoleculargeneticclassification
AT kopectomasz headandneckparagangliomasclinicalandmoleculargeneticclassification
AT patocsattila headandneckparagangliomasclinicalandmoleculargeneticclassification
AT wohllknelson headandneckparagangliomasclinicalandmoleculargeneticclassification
AT malekpourmahdi headandneckparagangliomasclinicalandmoleculargeneticclassification
AT boedekercarstenc headandneckparagangliomasclinicalandmoleculargeneticclassification
AT neumannhartmutph headandneckparagangliomasclinicalandmoleculargeneticclassification